The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells according to a study published in Nature Communications. Researchers from the Babraham Institute, AstraZeneca and the Cancer Research UK Cambridge Centre have demonstrated an approach, used in parallel with existing treatments, which knocks out one of melanoma cells’ survival pathways and is effective at triggering tumour cell death and delaying treatment resistance. The researchers suggest this approach may also help to tackle late stage cancers even after they have become resistant to existing treatments.
To learn more, see original article at: https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2019-11-14-blocking-a-survival-mechanism-could-tackle-melanoma-treatment-resistance
